Gaylyn, an IBD and ostomy advocate talks about the importance of representation Results consistently showed that individuals in the highest quintile of calcium intake had a lower incidence. The optimal delivery method is unclear for pregnant women with inactive perianal Crohn's disease. Researchers observed that people who carried the HLA-DRB1*01:03 allele were more than 3 times more likely to have severe UC Dr. Cedric Pulliam Shares his IBD Journey & Patient Advocacy Work Actigraphs showed that patients with fatty liver disease woke 55% more often at night compared to healthy volunteers Gaylyn, an IBD Advocate and IBD Social Circle Partner shares her story and talks about IBD and Ostomy awareness. diets high in ultra-processed foods (UPFs) may increase the risk for relapse in patients with Crohn’s disease (CD) who are ... Dr. Cedric Pulliam's personal journey to an IBD diagnosis and patient advocacy work to raise awareness. Dr. Larry Kosinski talks about the company he founded and how it helps facilitate IBD treatment. Dr. Larry Kosinski provided a detailed breakdown on IBD treatments, advancements, and health disparities. The education level of a mother may be linked to a child’s risk for IBD. A patient’s sex should be a factor considered by clinicians in the context of personalized medicine for IBD. A study explored social factors associated with delayed diagnosis of pediatric IBD. starting treatment earlier for people with newly diagnosed Crohn’s Disease can dramatically improve their gut health Patients with IBD reported that bowel urgency and bowel urgency-related accidents have a large effect on their daily lives. Research indicates that barriers to accessing treatments and other health care resources exist for patients with IBD. A new study has identified racial/ethnic disparities related to health-related quality of life among patients with UC. studies have found that early diagnosis is crucial for effective treatment and better outcomes A study identified certain factors that may be associated with a delay in the initiation of biologic treatment in IBD.